RPRX
Royalty Pharma·NASDAQ
--
--(--)
--
--(--)
9.41 / 10
Outperform
Analyst coverage is limited but highly positive: one analyst rates Strong Buy, yielding a 100% historical win rate. Sentiment score is 9.41 and fund‑flow score 7.82, with overall inflow positive and extra‑large investors buying, though small‑, medium‑ and large‑size flows are slightly negative.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Geoff MeachamStrong Buy
Date2026-01-27
InstitutionCitigroup
Times predicted2
Historical Win Rate100.0%
What is the market sentiment for RPRX?
- RPRX holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 9.41/10 (Outperform).
